Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

BRAF mutations in non-Hodgkin's lymphoma.

J W Lee1, N J Yoo, Y H Soung

  • 1Department of Pathology, College of Medicine, The Catholic University of Korea, 505 Banpo-dong, Socho-gu, Seoul 137-701, Korea.

British Journal of Cancer
|November 13, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Amsterdam Placental Workshop Group Consensus Statement definitions revisited: Basal chronic villitis.

Virchows Archiv : an international journal of pathology·2025
Same author

Antiarrhythmic drugs and anaesthesia. Part 2: pharmacotherapy.

BJA education·2023
Same author

Antiarrhythmic drugs and anaesthesia: part 1. mechanisms of cardiac arrhythmias.

BJA education·2023
Same author

Risk Factors that Predict Levothyroxine Medication after Thyroid Lobectomy.

Acta endocrinologica (Bucharest, Romania : 2005)·2021
Same author

Antimicrobial therapy during cancer treatment: Beyond antibacterial effects.

Journal of internal medicine·2020
Same author

Long-term mortality of patients with tuberculosis in Korea.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2020

This study investigated BRAF mutations in non-Hodgkin's lymphoma (NHL). BRAF mutations were found in 2.4% of NHL cases, suggesting a potential role in lymphoma development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Ras proteins are crucial regulators of cell growth and cancer development.
  • BRAF, a downstream component of the Ras pathway, is frequently mutated in various human cancers.
  • The role of BRAF mutations in non-Hodgkin's lymphoma (NHL) remained unexplored.

Purpose of the Study:

  • To investigate the frequency and nature of BRAF gene mutations in a cohort of non-Hodgkin's lymphoma patients.
  • To determine if BRAF mutations contribute to the pathogenesis of NHL.

Main Methods:

  • Genomic DNA was extracted from 164 NHL samples.
  • Polymerase chain reaction (PCR) coupled with single-strand conformation polymorphism (SSCP) was employed to screen for BRAF mutations.
  • Exons 11 and 15 of the BRAF gene were analyzed for somatic mutations.

Related Experiment Videos

Main Results:

  • BRAF mutations were identified in 4 out of 164 (2.4%) NHL cases.
  • Unlike mutations typically found in other cancers (e.g., V599), all identified BRAF mutations in NHL occurred at different amino acid positions.
  • Specific mutations detected included G468A (one case), G468R (two cases), and D593G (one case).

Conclusions:

  • This study provides the first evidence of BRAF mutations in non-Hodgkin's lymphoma.
  • BRAF mutations are infrequent but present in NHL.
  • These findings suggest that BRAF mutations may play a role in the oncogenesis of a subset of NHL cases.